👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

FIVE at FIVE AU: ASX to finish higher as Downer EDI soars

Published 30/08/2024, 02:41 pm
© Reuters.  FIVE at FIVE AU: ASX to finish higher as Downer EDI soars
DOW
-
AXSO
-

The ASX will finish the week higher as we launch into the final hour of trading.

At 3pm, the S&P/ASX200 had gained 37.40 points or 0.46% to 8,082.50. Over the last five days, the index has gained 0.73% and is currently 0.81% off of its 52-week high.

The top-performing stocks in this index at the time of writing were Downer EDI Ltd and Fletcher Building Ltd, up 18.93% and 10.27% respectively.

The best-performing sectors were Energy and Industrials, up 1.71 and 1.40% respectively. It was the Consumer sectors that were hit hardest with Consumer Discretionary and Consumer Staples losing 0.82% and 0.42% respectively.

Over on the small caps index, the S&P/ASX Small Ordinaries jumped 0.82% higher to 2,991.70. Over the past five days, the index has lost 0.83%.

Downer on the up

Downer EDI reported its financial results for the fiscal year ending June 30, 2024.

The company achieved a 34% increase in pro forma earnings before interest, taxes and amortisation (EBITA), amounting to $384.1 million, with an EBITA margin growth of 0.7 percentage points, bringing the margin to 3.3%.

Notably, the EBITA margin in the second half of FY24 rose to 4.0%, up from 3.0% in the same period last year.

The company’s statutory net profit after tax (NPAT) stood at $82.1 million. Key highlights include the return of the Utilities business to profitability, improved margins in the Facilities business, progress in cost reduction efforts, and the delivery of cash-backed profits.

Managing director and CEO Peter Tompkins said: “Over the past 18 months, we have refreshed our leadership team and made significant changes to our operating model and organisational structure, to redefine roles, authorities, and accountability for performance.

“We are making good progress in our business turnaround, delivering a cash-backed result alongside double digit underlying and pro forma EBITA and NPATA growth, whilst focusing on reducing the risk profile of our portfolio and strengthening our balance sheet.

“The result demonstrates our ability to deliver earnings and EBITA margin improvement in varied market conditions within our enhanced risk guardrails. It also highlights the resilience of our diversified and high-quality portfolio, the benefits of scale and our capacity to achieve operating and cost efficiencies.

“During the year we achieved $130 million in annualised gross cost-out, surpassing our initial target of $100 million. We are now focused on realising the full $175 million in annualised cost-out target with a clear plan to achieve the remaining $45 million by the end of FY25.”

Fletcher Building announces industry response to WA plumbing issues

Fletcher Building announced that its subsidiary, Iplex Pipelines Australia, in collaboration with the Western Australian Government and key industry stakeholders, has reached an in-principle agreement to address plumbing failures in some Western Australian homes constructed with Typlex Pro-Fit pipe.

This agreement, referred to as the Joint Industry Response (JIR), aims to rectify the issues that have arisen due to these plumbing failures. The company expects to record a pre-tax provision of some A$155 million in its FY25 financial statements, contingent upon the finalisation of the JIR.

Ramsay Health hits 52-week low amid profit decline

On the flipside, Ramsay Health Care Ltd shares declined by 8% intra-day, reaching a 52-week low of $40.94, following the release of its full-year results for FY 2024.

The company's total revenue increased by 9.4% to $16,772.1 million, driven by higher patient activity and new capacity.

However, the EBIT from continuing operations decreased by 0.4% to $997.6 million, primarily due to a decline in earnings from Ramsay Santé, despite improvements in Australia and the UK.

Notably, non-recurring items had a negative impact of $36.4 million on EBIT, contrasting with a $42.1 million benefit in the previous year. Excluding these items, EBIT rose 6.1% in constant currency to $1,034 million.

Profit after tax from continuing operations fell by 2.7% to $270.6 million. Despite the decrease in profit, the company increased its full-year dividend by 6.7% to 80 cents per share, offering a dividend yield of around 2%.

“I am pleased to report an operating result that reflects the benefits of growing patient activity and productivity improvement programs across all of our regions. We have made some progress with private sector payors on tariff indexation, however tariffs from payors remain out of touch with cost inflation,” Ramsay CEO Craig McNally.

“Margin recovery has been slowed by the significant cost inflation impacting the private hospital industry over the last few years. Wage inflation exceeding expectations remains a critical risk. Tariff outcomes for the UK and France from April 1 and March 1, 2024, respectively were well below recent inflation levels making earnings growth in both markets challenging in FY25.”

Five at five

Synertec lifts group income and revenue 26% and customer cash receipts 31% in 2024 financial year

Synertec Corporation Ltd (ASX:SOP) notched a 26% increase in revenue and other incomes to bring in $19.7 million this financial year, with the growth mostly driven by expansions to its engineering services and contracts for its standalone micro-grid renewable energy and storage solution, Powerhouse.

Read more

Cyprium Metals enters $40 million loan facility with Glencore (LON:GLEN) to bring Nifty’s copper products to market

Cyprium Metals Ltd (ASX:CYM, OTC:CYPMF) has entered into a binding term sheet with Glencore International AG for A$40 million in offtake financing.

Read more

Carnarvon Energy sharpens focus on Dorado project with sustainability at the forefront

Carnarvon Energy Ltd (ASX:CVN) has outlined its development pathway for the Dorado Project off the coast of Western Australia in its 2024 sustainability report, with a focus on balancing both energy demands and environmental responsibility.

Read more

Novo Resources extends high-grade Main Lode to 500 metres at Nunyerry North, Egina Gold Camp, WA

Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) has made broad progress at the Egina Gold Camp joint venture (JV) in the Pilbara region of Western Australia, extending the high-grade Main Lode at Nunyerry North to 500 metres of strike and striking high-grade gold along the Estrid Fault.

Read more

Antipa Minerals confirms gold mineralisation at Minyari Dome Pacman targets

Diamond core drilling results have confirmed gold mineralisation at Antipa Minerals Ltd (ASX:AZY)’s 100%-owned Minyari Dome Gold-Copper Project in the Paterson Province of Western Australia.

Read more

On your six

Regenerative medicine’s many applications are changing the face of health care

Unlike traditional treatments that aim to manage symptoms, regenerative medicine seeks to address the root cause of a condition by deploying the body’s own repair mechanisms or by introducing new, healthy cells to work with the body.

Read more

The one to watch

archTIS reports record revenue growth and strong cash flow

archTIS Ltd CEO Daniel Lai joins Proactive’s Tylah Tully to discuss its 2024 financial year, which was highly successful with the company reporting a 54% increase in revenue and a positive operating cash flow of A$1.6 million.

Watch

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.